Back to company

BioMed Invest ApS: Financial statements 2016

CVR: 29844925

BioMed Invest ApS (CVR 29844925) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 77,280 and a net result of DKK -771,035 compared with DKK 218,041 the year before. Equity amounted to DKK 1,864,350. The solvency ratio was 86.5%.

Gross Profit
77,280 kr.
Profit/Loss
-771,035 kr.
Equity
1,864,350 kr.
Total Assets
2,154,802 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-77 t.-771 t.1.9 mio.-
2015--218 t.2.7 mio.-
2014-72 t.708 t.2.6 mio.-
2013-77 t.212 t.1.9 mio.-
2012-10 t.447 t.1.8 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is BioMed Invest ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

BioMed Invest ApS: The 2015 annual report is outMay 26, 2016

BioMed Invest ApS has published its annual report for 2015. The net result was DKK 218,041.

About BioMed Invest ApS

BioMed Invest ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2006. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Erling Henningsen. The company is owned by Erling Henningsen. In 2025, the company reported a gross profit of DKK 12,474 and a net result of DKK -80,320 compared with DKK 451,303 the year before. Equity amounted to DKK 8,740,167.